Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38283
CAS Number:
50-35-1
±)-Talidomida
Purity:
≥ 98 % (HPLC)
Synonym(s):
N- (2,6-dioxo-3-piperidinil)ftalimida
Hazmat
Documents
$189.58 /1G
Tamaño
Request Bulk Quote
Información del producto
Número CAS
50-35-1
Fórmula molecular
C13H10N2O4
Peso molecular
0
Número MDL
MFCD00153873
Punto de fusión
275 - 277 °C
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
50-35-1
Fórmula molecular
C13H10N2O4
Peso molecular
0
Número MDL
MFCD00153873
Punto de fusión
275 - 277 °C
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

(±)-Thalidomide is widely utilized in research focused on

  • Multiple Myeloma Treatment: This compound is approved for treating multiple myeloma, a type of blood cancer. Its ability to inhibit tumor growth and modulate the immune system makes it a valuable option for patients.
  • Leprosy Management: Thalidomide is effective in treating complications of leprosy, particularly erythema nodosum leprosum, providing relief from painful skin lesions and inflammation.
  • Anti-Inflammatory Applications: Due to its immunomodulatory properties, it is used in treating various inflammatory conditions, including Crohn's disease and ulcerative colitis, offering an alternative for patients who do not respond to conventional therapies.
  • Research in Angiogenesis: Thalidomide is studied for its role in inhibiting angiogenesis, the formation of new blood vessels, which is crucial in cancer progression and other diseases, making it a key focus in cancer research.
  • Potential in Autoimmune Disorders: Ongoing research is exploring its use in autoimmune diseases like lupus and rheumatoid arthritis, where it may help modulate the immune response and reduce symptoms.

Citas